As we are refreshing our thoughts on BioMerieux, we are reinstating our narrow moat rating. BioMerieux is a niche player in the fragmented in vitro diagnostic market and has specialty positioning in ...
BioMerieux’s strategy is threefold: maintain market leadership in the niche areas of microbiology and syndromic testing, continue to expand the market in diagnostics in syndromic testing, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results